BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biotech

CryptoLab and Macrogen Ink Deal to Integrate Advanced Encryption in Genomic Services

CryptoLab, a pioneer of fully homomorphic encryption (FHE) technology has announced the signing of a three-year supply contract with Macrogen, Korea'...

April 18, 2024 | News

Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing

Proprietary Aptegra™ platform reduces five assays to one Results in 66% faster testing time and significantly lower cost for clients compared to t...

April 17, 2024 | News

Merck Champions Innovative Health Education to Tackle Schistosomiasis in Ethiopia

Merck invests in health education initiatives for behavior change as part of its integrated approach to schistosomiasis. On March 22, 2024, the company ...

April 03, 2024 | News

Merck Invests Over €300 Million in New Daejeon Bioprocessing Center, Elevating Asia-Pacific's Biologics Sector and Generating 300 Jobs

Site to supply products to customers for development and production of biologics New Bioprocessing Production Center in Daejeon strengthens footprint of...

March 20, 2024 | News

Innovating for Health Equity: Takeda's Blueprint for Medicine Access in APAC with Dion Warren

In an illuminating conversation with BioPharma APAC, Dion Warren, the Head of Multi-Country Organization, India and Southeast Asia ...

March 04, 2024 | Interview

William Lin Discusses QIAGEN's Role in Transforming Healthcare in Asia-Pacific with Innovative Molecular Diagnostics

In a significant stride towards enhancing healthcare diagnostics in the Asia-Pacific region, QIAGEN has recently garnered attention with the approval of it...

February 13, 2024 | Interaction

Merck's Strategic Agreement with Heavy Water Board Boosts Local Manufacturing for Deuterated Compounds in India

In a recent interview with BioPharma APAC, Jean Charles Wirth, Executive Vice President of Science & Laboratory Solutions at Merck, sheds light...

January 26, 2024 | Interview

Merck and Mycenax Biotech Forge Partnership for Bioprocessing Innovation

Merck announces a non-binding MoU with Mycenax Biotech to optimize bioprocessing production of life-changing biological therapies Integrates company&rsq...

January 24, 2024 | News

Thermo Fisher's RNA Facility in Monza, Italy, Gains GMP Approval from Italian Medicines Agency (AIFA)

Thermo Fisher Scientific, the world leader in serving science, has received Good Manufacturing Practice (GMP) approval from the Italian Medicines Agency (A...

January 19, 2024 | News

Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna

First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...

January 09, 2024 | News

Thermo Fisher Introduces PangenomiX Array for Large-Scale Disease and Pharmacogenomics Research

Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people around the world to create a more ...

January 05, 2024 | News

Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC

In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...

December 18, 2023 | News

Inside the World of Cell Therapies: Illuminating the Future of Cancer Care

The Rise of Cell Therapies in Cancer Care Recent years have witnessed significant strides in the development and application of cell therapies for cancer ...

December 13, 2023 | News

Plenary Session on Biotech Ecosystem: Views from Key Opinion Leaders Highlights at #GlobalBioIndia2023: A Glimpse into the Future of Biotech Innovation

This pivotal evolution was underscored by Rajesh Gokhale, Secretary, Department of Biotechnology, and Chairman of the Biotechnology Industry Research Assis...

December 05, 2023 | News

Stay Connected